Table: Kaken Pharmaceutical - 6-MTH group results

KAKEN PHARMACEUTICAL

06/11/2018 04:30

Nov 6 (Reuters)- 
             Kaken Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2018        Sep 30, 2017     Mar 31, 2019 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             47.52               49.86            94.80    
                 (-4.7 pct)          (-4.4 pct)       (-3.7 pct)  
  Operating         12.36               15.34            22.50    
                 (-19.4 pct)         (-4.9 pct)       (-18.2 pct) 
  Recurring         12.54               15.52            22.80    
                 (-19.2 pct)         (-4.4 pct)       (-18.1 pct) 
  Net                8.84               10.87            16.40    
                 (-18.7 pct)         (-5.1 pct)       (-13.9 pct) 
  EPS            220.84 yen          267.56 yen       412.90 yen  
  Ann Div                            150.00 yen       150.00 yen  
  -Q2 div         75.00 yen           75.00 yen                   
  -Q4 div                             75.00 yen        75.00 yen  
  
  NOTE - Kaken Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T